Who are methyl prednisolone acetate's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Solu-medrol or placebo administration, Prednisone/Prednisolone/Methylprednisolone, phosphate and betamethasone acetate, 2 mL., every week IVMP therapy, Local steroid - triamcinolone acetonide, Prednisone 6 weeks.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/methyl-prednisolone-acetate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

methyl prednisolone acetate — Competitive Intelligence Brief

methyl prednisolone acetate (methyl prednisolone acetate) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Corticosteroid (glucocorticoid). Area: Immunology, Rheumatology, Dermatology, Endocrinology.

marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR) Immunology, Rheumatology, Dermatology, Endocrinology Small molecule Live · refreshed every 30 min

Target snapshot

methyl prednisolone acetate (methyl prednisolone acetate) — Benazir Bhutto Hospital, Rawalpindi. Methylprednisolone acetate is a synthetic corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
methyl prednisolone acetate TARGET	methyl prednisolone acetate	Benazir Bhutto Hospital, Rawalpindi	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
Solu-medrol or placebo administration	Solu-medrol or placebo administration	Erasme University Hospital	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
Prednisone/Prednisolone/Methylprednisolone	Prednisone/Prednisolone/Methylprednisolone	Hoffmann-La Roche	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
phosphate and betamethasone acetate, 2 mL.	phosphate and betamethasone acetate, 2 mL.	Hospital Italiano de Buenos Aires	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
every week IVMP therapy	every week IVMP therapy	Medical University of Warsaw	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor
Local steroid - triamcinolone acetonide	Local steroid - triamcinolone acetonide	Instituto do Cancer do Estado de São Paulo	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor
Prednisone 6 weeks	Prednisone 6 weeks	Xinqiao Hospital of Chongqing	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Corticosteroid (glucocorticoid) class)

Assistance Publique - Hôpitaux de Paris · 3 drugs in this class
Astellas Pharma Inc · 2 drugs in this class
Sanofi · 2 drugs in this class
Xinqiao Hospital of Chongqing · 2 drugs in this class
Berinstein, Jeffrey · 2 drugs in this class
Ain Shams University · 2 drugs in this class
Children's Hospital of Philadelphia · 1 drug in this class
Celgene · 1 drug in this class
Hamilton Health Sciences Corporation · 1 drug in this class
Erasme University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). methyl prednisolone acetate — Competitive Intelligence Brief. https://druglandscape.com/ci/methyl-prednisolone-acetate. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab